Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT00176644
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class
Stopped
Treatment ineffective
Conditions
Prostate Cancer
Interventions
DRUG:
Transdermal Estradiol
Sponsor
University of Medicine and Dentistry of New Jersey
Collaborators
[object Object]